title: Administration of neomycin resistance gene marked EBV specific cytotoxic T-lymphocytes to patients with relapsed EBV-positive Hodgkin disease.
authors.affiliation: Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX 77030, USA.
authors.forename: M A
authors.initials: MA
authors.lastname: Roskrow
authors.forename: C M
authors.initials: CM
authors.lastname: Rooney
authors.forename: H E
authors.initials: HE
authors.lastname: Heslop
authors.forename: M K
authors.initials: MK
authors.lastname: Brenner
authors.forename: R A
authors.initials: RA
authors.lastname: Krance
authors.forename: M V
authors.initials: MV
authors.lastname: Gresik
authors.forename: K
authors.initials: K
authors.lastname: McClain
authors.forename: L K
authors.initials: LK
authors.lastname: Aguilar
authors.forename: B
authors.initials: B
authors.lastname: Grilley
authors.forename: E
authors.initials: E
authors.lastname: Rob
authors.forename: G
authors.initials: G
authors.lastname: Carrum
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002460:Cell Line; D004352:Drug Resistance, Microbial / Q000235:genetics; D005240:Feasibility Studies; D005814:Genes, Viral; D005819:Genetic Markers; D005822:Genetic Vectors; D004854:Herpesvirus 4, Human / Q000235:genetics*; D006689:Hodgkin Disease / Q000821:virology*; D006801:Humans; D007275:Injections, Intravenous; D009355:Neomycin / Q000494:pharmacology*; D009364:Neoplasm Recurrence, Local; D012190:Retroviridae / Q000235:genetics; D013602:T-Lymphocytes, Cytotoxic
chemical_list: D000900:Anti-Bacterial Agents; D005819:Genetic Markers; D009355:Neomycin